No black box warning on record for Pimozide

As of the latest FDA labeling reviewed, Pimozide (PIMOZIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Pimozide medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS The use of pimozide in the treatment of Tourette’s Disorder involves different risk/benefit considerations than when antipsychotic drugs are used to treat other conditions. Consequently, a decision to use pimozide should take into consideration the following (see also PRECAUTIONS - Information for Patients ). Tardive Dyskinesia A syndrome consisting of potentially irreversible, involuntar

No black box warning on record for Pimozide

Other warnings & precautions

WARNINGS The use of pimozide in the treatment of Tourette’s Disorder involves different risk/benefit considerations than when antipsychotic drugs are used to treat other conditions. Consequently, a decision to use pimozide should take into consideration the following (see also PRECAUTIONS - Information for Patients ). Tardive Dyskinesia A syndrome consisting of potentially irreversible, involuntar

Pimozide Black Box Warning

No black box warning on record for Pimozide

Other warnings & precautions

Pimozide Black Box Warning

No black box warning on record for Pimozide

Other warnings & precautions